ImmuCell Corporation
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-168.1K | $508.4K | $1.2M | $-167.2K | $117.4K | $89.5K | $-409.5K | $-384.7K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $885.3K | $783.3K | $525.9K | $446.0K | $414.3K | $399.6K | $413.1K | $416.9K |
| Amortization | $19.1K | $19.1K | — | — | — | — | — | — |
| Stock-Based Compensation | $199.8K | $67.4K | $23.2K | $30.0K | $31.4K | $36.0K | $38.2K | $29.5K |
| Net Cash from Operating Activities | $1.2M | $-222.3K | $2.9M | $302.4K | $1.1M | $344.4K | $-37.3K | $-808.6K |
| Investing Activities | ||||||||
| Capital Expenditures | $17.8M | $3.6M | $2.7M | $1.5M | $597.7K | $275.4K | $243.7K | $116.5K |
| Business Acquisitions | — | $532.0K | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-12.3M | $-4.5M | $-4.6M | $-1.5M | $-1.3M | $1.7M | $-1.2M | $266.5K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $9.7M | $8.3M | $2.4M | $-187.2K | $-159.3K | $-114.8K | $614.6K | $965.7K |
| Net Change in Cash | $-1.4M | $3.6M | $723.3K | $-1.4M | $-403.3K | $1.9M | $-617.5K | $423.5K |
| Free Cash Flow | $-16.6M | $-3.8M | $181.0K | $-1.2M | $501.0K | $69.0K | $-281.1K | $-925.2K |